MATINAS BIOPHARMA HOLDINGS, INC. Prepaid Expense and Other Assets, Current
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Prepaid Expense and Other Assets, Current of $332.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense and Other Assets, Current $332.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $367.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $26.00K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $168.00K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $332.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $367.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $26.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $168.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $693.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $573.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $691.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $896.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $922.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.13M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.74M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $1.72M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $1.44M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $3.30M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $5.72M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $4.00M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $3.37M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.20M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.32M 10-K · filed 2023-03-15 | $1.32M 10-K · filed 2022-03-08 |
| 2021-09-30 | $2.60M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $960.42K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $2.33M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $2.74M 10-K/A · filed 2022-03-11 | |
| 2020-09-30 | $2.25M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $1.05M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $2.67M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.90M 10-K · filed 2021-03-29 | |
| 2018-12-31 | $538.65K 10-K · filed 2020-03-09 | |
| 2017-06-30 | $317.25K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $803.04K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $304.43K 10-Q · filed 2017-08-08 | |
| 2016-09-30 | $254.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $139.64K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $138.02K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $231.80K 10-K · filed 2017-03-31 | |
| 2015-09-30 | $342.19K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $115.00K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $93.63K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $114.42K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $108.06K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $38.06K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $87.63K 10-Q · filed 2014-06-06 | |
| 2013-12-31 | $84.49K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |